These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2526419)

  • 1. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians.
    Hadler SC; de Monzon MA; Lugo DR; Perez M
    Vaccine; 1989 Apr; 7(2):106-10. PubMed ID: 2526419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of low doses of recombinant yeast-derived hepatitis B vaccine.
    Tan KL; Oon CJ; Goh KT; Wong LY; Chan SH
    Acta Paediatr Scand; 1990; 79(6-7):593-8. PubMed ID: 2143619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine administered to children and adolescents at yearly intervals.
    Halsey NA; Moulton LH; O'Donovan JC; Walcher JR; Thoms ML; Margolis HS; Krause DS
    Pediatrics; 1999 Jun; 103(6 Pt 1):1243-7. PubMed ID: 10353936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the hepatitis B recombinant DNA yeast vaccine (H-B-VAX II) in children: two doses vs. three doses of 5 micrograms regime; an interim report.
    Lai CL; Yeoh EK; Chang WK; Lo VW; Ng LN
    J Infect; 1986 Jul; 13 Suppl A():19-25. PubMed ID: 2943812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
    Milne A; Moyes CD; Dimitrakakis M
    N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
    Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast-derived hepatitis B vaccine in dental students. A three-year follow-up study.
    Zanetti AR; Tanzi E; Pozzi A; Romano L; Bergamini F
    Vaccine; 1990 Jun; 8(3):205-8. PubMed ID: 2194379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and reactogenicity of a combined hepatitis A and B vaccine in young adults.
    Bruguera M; Bayas JM; Vilella A; Tural C; González A; Vidal J; Dal-Ré R; Salleras L
    Vaccine; 1996 Oct; 14(15):1407-11. PubMed ID: 8994314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of low doses of hepatitis B vaccine in normal children.
    Matsaniotis N; Kattamis C; Dionyssopouolou E; Laskari S
    Vaccine; 1985 Sep; 3(3):297-9. PubMed ID: 3904258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.
    Inskip HM; Hall AJ; Chotard J; Loik F; Whittle H
    Int J Epidemiol; 1991 Sep; 20(3):764-9. PubMed ID: 1835452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of initiating a hepatitis B vaccination schedule with one vaccine and completing it with another.
    Bush LM; Moonsammy GI; Boscia JA
    Vaccine; 1991 Nov; 9(11):807-9. PubMed ID: 1836921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two dose combined hepatitis A and B vaccine in Chinese youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Chang FY; Lo KJ; Safary A
    J Med Virol; 1999 Sep; 59(1):1-4. PubMed ID: 10440800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of hepatitis B vaccination into rural African primary health care programmes.
    Schoub BD; Johnson S; McAnerney JM; Blackburn N; Kew MC; McCutcheon JP; Carlier ND
    BMJ; 1991 Feb; 302(6772):313-6. PubMed ID: 1825799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a DNA-recombinant hepatitis B vaccine (Engerix B) given at 3, 5 and 11 months of age with a new schedule suitable for mass vaccination programmes.
    Piazza M; Da Villa G; Picciotto L; Abrescia N; Guadagnino V; Vegnente A; Iorio R; Cimmino L; Memoli AM
    Boll Soc Ital Biol Sper; 1989 Oct; 65(10):1003-8. PubMed ID: 2533872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of minimal doses of an American hepatitis B vaccine in neonates.
    Scaravelli C; Bianchi E; Biraghi V; Mariani G; Calligari GC; Lucchesi P; De Leo G
    Clin Ther; 1985; 7(6):680-3. PubMed ID: 2934134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.
    Cassidy WM; Watson B; Ioli VA; Williams K; Bird S; West DJ
    Pediatrics; 2001 Apr; 107(4):626-31. PubMed ID: 11335734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified immunisation schedule for the hepatitis B vaccine Recombivax HB suitable for mass vaccination in childhood.
    Piazza M; Abrescia N; Picciotto L; Cotugno M; Vegnente A; Iorio R; Cimmino L
    Boll Soc Ital Biol Sper; 1991 Feb; 67(2):207-11. PubMed ID: 1832284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.